Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation

Europace

Volumn 12, Issue 3, 2010, Pages 364-370

  Arribas, Fernando ^a   Ormaetxe, José Miguel ^b   Peinado, Rafael ^c   Perulero, Nuria ^d   Ramírez, Patricia ^e   Badia, Xavier ^d  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d IQVIA   (United States)

^e Meda Pharmaceuticals   (Spain)

Author keywords

Atrial fibrillation; Health related quality of life; Questionnaires; Validation

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SELF CONCEPT; SHORT FORM 36; SPAIN; SYMPTOM; TEST RETEST RELIABILITY; VALIDATION PROCESS;

AGED; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SPAIN;

EID: 77749333547     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup421     Document Type: Article

References (26)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Am Med Assoc 2001;285:2370-5.
2. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25.
3. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006;119:448. e1-419.
4. Lüderitz B, Jung W. Quality of life in patients with atrial fibrillation. Arch Intern Med 2000;160:1749-57.
5. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354.
6. Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol 2004;43:241-7.
7. Dorian P, Paquette M, Newman D, Green M, Connolly SJ, Talajic M et al. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J 2002;143:984-90.
8. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000;36:1303-9.
9. Reynolds MR, Ellis E, Zimetbaum P. Quality of life in atrial fibrillation: measurement tools and impact of interventions. J Cardiovasc Electrophysiol 2008;19:762-8.
10. Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M et al. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation: APT investigators. J Intervent Card Electrophysiol 1998;2:121-35.
11. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr et al. Cicumferential pulmonary-vein ablation for chronic atrial fibrilation. N Engl J Med 2006;354: 934-41.
12. Bragança EO, Filho BL, Maria VH, Levy D, de Paola AA. Validating a new quality of life questionnaire for atrial fibrillation patients. Int J Cardiol 2009; doi:10.1016/j.ijcard.2009.03.087. Published online ahead of print 22 April 2009.
13. Badia X, Arribas F, Ormaetxe JM, Peinado R, Sainz de los Terreros M. Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL). Health Qual Life Outcomes 2007;5:37-44.
14. Cohen J. Statistical Power Analysis for Behavioural Sciences. 2nd ed. New Jersey: Lawrence Eribaum Associates Inc.; 1988.
15. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J 2007;28: 2803-17.
16. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
17. Relation between achieved Heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillatin Follow-up Investigation of Rhythm Management [AFFIRM] study). Am J Cardiol 2004;93:1247-53.
18. Reynolds MR, Essebag V, Zimetbaum P, Cohen DJ. Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: The FRACTAL Registry. J Cardiovasc Electrophysiol 2007;18:628-33.
19. Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R et al. An evaluation of the strategy of maintenance of sinus rhythm by anti-arrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. Eur Heart J 2002;23:892-900.
20. Weerasooriya R, Davis M, Powell A, Szili-Torok T, Shah C, Whalley D et al. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol 2003;41:1697-702.
21. Singh SN, Singh BN, Reda DJ, Fye CL, Ezekowitz MD, Fletcher RD et al. Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [SAFE-T]). Am J Cardiol 2003;92:468- 72.
22. Paquette M, Roy D, Talajic M. Role of gender and personality on QoL impairment in intermittent atrial fibrillation. Am J Cardiol 2000;86:764-8.
23. Dorian P, Cvitkovic S, Kerr CR, Crystal E, Gillis A, Guerra P et al. A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF Scale. Can J Cardiol 2006;22:383-6.
24. Hegbom F, Stavem K, Sire S, Heldal M, Orning OM, Gjesdal K. Effects of short term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation. Int J Cardiol 2007;116:86-92.
25. Kang Y. Relation of atrial arrhythmia-related symptoms to health-related quality of life in patients with newly diagnosed atrial fibrillation: a community hospital-based cohort. Heart Lung 2006;35:170-7.
26. Badia X, Schiaffino A, Alonso J, Herdman M. Using the EuroQoL 5-d in the Catalan general population: feasibility and construct validity. Qual Life Res 1998;7:311-22.